Abstract
Objective: In the current research study, a colon targeted pulsatile drug delivery system (PDDS) of venlafaxine hydrochloride (VH) was designed for chronotherapy of depression.
Method: A capsular device was designed having body insoluble throughout gastrointestinal tract (GIT) fluid and cap soluble in small intestine fluid. The granules of VH was filled in the body and separated from the cap with the help of a hydrophilic polymer plug. Plugs were made up of blend of HPMC K100M and xanthan gum (1:1). Finally, an enteric coating was applied on entire capsule using 5 %w/v ethylcellulose (EC) solution. Results: In in vitro release studies, the enteric coat of the EC was insoluble for 2 h in pH 1.2 (stomach), but get solubilized in pH 7.4 phosphate buffer (small intestine). The cap of the capsule solubilizes in pH 7.4, which exposed the hydrophilic plug to absorb the nearby fluid and swell. After maximum swelling, the plugs got ejected out from the capsule body causing the release of VH granules into colon (pH 6.8 phosphate buffer). Conclusion: Formulations containing high amount of polymer in plug showed 5 h lag time, which was considered optimum for a delivery system to reach colon and release the drug.Keywords: Pulsatile, chronotherapy, colon, venlafaxine, depression, HPMC, xanthan gum.
Current Psychopharmacology
Title:Colon Targeted Pulsatile Drug Delivery System of Venlafaxine Hydrochloride for Treatment of Depression
Volume: 6
Author(s): Ajay Kumar, Ankaj Kaundal, Mahendra S. Ashawat, Vinay Pandit and Pravin Kumar*
Affiliation:
- Department of Pharmaceutics, Laureate Institute of Pharmacy, VPO-Kathog, Tehsil- Dehra, Distt.-Kangra, H.P-177101,India
Keywords: Pulsatile, chronotherapy, colon, venlafaxine, depression, HPMC, xanthan gum.
Abstract: Objective: In the current research study, a colon targeted pulsatile drug delivery system (PDDS) of venlafaxine hydrochloride (VH) was designed for chronotherapy of depression.
Method: A capsular device was designed having body insoluble throughout gastrointestinal tract (GIT) fluid and cap soluble in small intestine fluid. The granules of VH was filled in the body and separated from the cap with the help of a hydrophilic polymer plug. Plugs were made up of blend of HPMC K100M and xanthan gum (1:1). Finally, an enteric coating was applied on entire capsule using 5 %w/v ethylcellulose (EC) solution. Results: In in vitro release studies, the enteric coat of the EC was insoluble for 2 h in pH 1.2 (stomach), but get solubilized in pH 7.4 phosphate buffer (small intestine). The cap of the capsule solubilizes in pH 7.4, which exposed the hydrophilic plug to absorb the nearby fluid and swell. After maximum swelling, the plugs got ejected out from the capsule body causing the release of VH granules into colon (pH 6.8 phosphate buffer). Conclusion: Formulations containing high amount of polymer in plug showed 5 h lag time, which was considered optimum for a delivery system to reach colon and release the drug.Export Options
About this article
Cite this article as:
Kumar Ajay, Kaundal Ankaj, Ashawat S. Mahendra, Pandit Vinay and Kumar Pravin*, Colon Targeted Pulsatile Drug Delivery System of Venlafaxine Hydrochloride for Treatment of Depression, Current Psychopharmacology 2017; 6 (1) . https://dx.doi.org/10.2174/2211556006666161221113127
DOI https://dx.doi.org/10.2174/2211556006666161221113127 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nasal Polyposis: From Pathogenesis to Treatment, An Update
Inflammation & Allergy - Drug Targets (Discontinued) Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases
Current Neuropharmacology Chemical and Potential Biological Perspectives of Genus Sarcococca (Buxaceae)
The Natural Products Journal Histone Deacetylation and Motor Neuron Degeneration
CNS & Neurological Disorders - Drug Targets Arachidonate Cascade in the Intensive Insulin Therapy for Critically Ill Patients with Sepsis: Roles of Prostaglandins on Hyperglycemia-Impaired Immunity
Letters in Drug Design & Discovery Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Current Outcomes and Future Perspectives of Cochlear Implants
Current Drug Therapy CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Current Pharmaceutical Design Role of Oxygen Radicals on Bronchial Asthma
Current Drug Targets - Inflammation & Allergy Weight Loss Following Roux-en-Y Gastric Bypass Surgery: A Systematic Review of Psychosocial Predictors
Current Psychiatry Reviews Donkeys and Goats Milk Consumption and Benefits to Human Health with Special Reference to the Inflammatory Status
Current Pharmaceutical Design Effects of Erythropoietin on Brain Function
Current Pharmaceutical Biotechnology Melatonin and Renal Protection: Novel Perspectives from Animal Experiments and Human Studies (Review)
Current Pharmaceutical Design Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery
Current Pharmaceutical Design GMP-Automated Purification of Copper-61 Produced in Cyclotron Liquid Targets: Methodological Aspects
Current Radiopharmaceuticals The Relevance of Supplemental Vitamin D in Malignancies
Anti-Cancer Agents in Medicinal Chemistry Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids
Medicinal Chemistry Regulatory Light Chains of Striated Muscle Myosin. Structure, Function and Malfunction
Current Drug Targets - Cardiovascular & Hematological Disorders IgG Dimers in Multidonor-Derived Immunoglobulins: Aspects of Generation and Function
Current Pharmaceutical Design Pharmacological Advances in the Treatment of Insomnia
Current Pharmaceutical Design